Cite
A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review
MLA
Meta H. M. Diekstra, et al. A Decade of Pharmacogenomics Research on Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn947714156&authtype=sso&custid=ns315887.
APA
Meta H. M. Diekstra, Jesse J. Swen, Hans Gelderblom, & Henk-Jan Guchelaar. (2016). A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.
Chicago
Meta H. M. Diekstra, Jesse J. Swen, Hans Gelderblom, and Henk-Jan Guchelaar. 2016. “A Decade of Pharmacogenomics Research on Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: A Systematic Review.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.ocn947714156&authtype=sso&custid=ns315887.